Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Vorinostat × Plasma cell × Clear all

Phase

Status

Completed 12 Terminated 4 Withdrawn 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Dexamethasone 59 Cyclophosphamide 39 Bortezomib 33 Melphalan 22 Lenalidomide 20 Thalidomide 16 pomalidomide 14 daratumumab 12 fludarabine 11 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Bendamustine Hydrochloride 5 ixazomib 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 selinexor 3 sargramostim 3 liposomal doxorubicin 3 isatuximab 3 dexamethasone acetate 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡